INSP Inspire Medical Systems, Inc. Common Stock
NYSE · Health Care · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 3, 2026
$69,97
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$38,9152tyg. minimum
$147,0352tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$2.02B
P/E (TTM)
15.4
EPS (TTM)
$4.53
Przychody (TTM)
$899M
Twoje odznaki
Zakres 52 tyg.
$39–$147
Ocena Analityków
HOLD
Cena Docelowa
$63
P/E
15.4
ROE
18.0%
Marża Zysku Netto
15.0%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
INSP Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$69.97
Kapitalizacja Rynkowa (MRQ)
$2.02B
P/E (TTM)
15.4
EPS (TTM)
$4.53
Przychody (TTM)
$899M
ROE (TTM)
18.0%
Zakres 52 tyg.
$39–$147
INSP Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
O Inspire Medical Systems, Inc. Common Stock Przegląd firmy z Wikipedii
sektorHealth Care
branżaHealth Care
pracownicy1 333
krajUS
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$912M2017-12-31 → 2025-12-31
EPS$4.892019-12-31 → 2025-12-31
Wolny przepływ pieniężny$78M2018-12-31 → 2025-12-31
Marża netto15.0%2018-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | INSP | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 15.4średnia z 5 lat ≈-92.9 | ≈-92.9 | 31.5 | Niedowartościowany | |
| P/S (TTM) | 2.3średnia z 5 lat ≈12.9 | ≈12.9 | 2.5 | Niedowartościowany | |
| P/B (MRQ) | 2.4średnia z 5 lat ≈12.8 | ≈12.8 | 3.2 | Niedowartościowany | |
| Cena / FCF (TTM) | 17.3średnia z 5 lat ≈1733.3 | ≈1733.3 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 12.9średnia z 5 lat ≈125.4 | ≈125.4 | 24.4 | Niedowartościowany | |
| Price / Tangible Book (Cena / Wartość księgowa materialna) | 2.6średnia z 5 lat ≈12.8 | ≈12.8 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | INSP | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 86.1%średnia z 5 lat ≈84.8% | ≈84.8% | 72.1% | Najwyższa półka | |
| Marża Operacyjna (TTM) | 6.0%średnia z 5 lat ≈-5.0% | ≈-5.0% | 3.0% | Poniżej średniej | |
| Marża EBITDA (TTM) | 7.9%średnia z 5 lat ≈-4.3% | ≈-4.3% | 3.0% | Poniżej średniej | |
| Marża przed opodatkowaniem (TTM) | 7.7%średnia z 5 lat ≈-3.5% | ≈-3.5% | 6.1% | Słaby | |
| Marża Zysku Netto (TTM) | 15.0%średnia z 5 lat ≈-2.0% | ≈-2.0% | 3.0% | Poniżej średniej | |
| ROA (TTM) | 15.6%średnia z 5 lat ≈-0.86% | ≈-0.86% | -0.86% | Najwyższa półka | |
| ROE (TTM) | 18.0%średnia z 5 lat ≈-1.4% | ≈-1.4% | -1.1% | Najwyższa półka | |
| ROIC | 14.4%średnia z 5 lat ≈-2.9% | ≈-2.9% | 0.08% | Najwyższa półka |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | INSP | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 8.6średnia z 5 lat ≈7.2 | ≈7.2 | 4.1 | Silna płynność | |
| Wskaźnik Szybkości (MRQ) | 6.0średnia z 5 lat ≈6.4 | ≈6.4 | 2.4 | Silna płynność |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | INSP | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 13.6%średnia z 5 lat ≈54.5% | ≈54.5% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 30.8%średnia z 5 lat ≈52.4% | ≈52.4% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 51.2% | · | · | · | |
| EPS YoY | 179.4% | · | · | · | |
| Net Income YoY (Zysk Netto R/R) | 171.8% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | INSP | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 1.1średnia z 5 lat ≈1.0 | ≈1.0 | 0.6 | Najwyższa półka | |
| Inventory Turnover (Rotacja zapasów) | 1.2średnia z 5 lat ≈2.9 | ≈2.9 | 1.6 | Słaby | |
| Receivables Turnover (Rotacja należności) | 8.6średnia z 5 lat ≈8.4 | ≈8.4 | 8.1 | Najwyższa półka | |
| Revenue / Employee (Przychody / pracownika) | ≈$684.2K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
112.2%
Następny raport
Lis 02, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 3, 2026 | $0.01 | $-0.28 | 103.6% |
| 31 marca 2026 | $-0.39 | $-0.28 | -37.6% | |
| 31 grudnia 2025 | $1.62 | $0.89 | 81.3% | |
| 30 września 2025 | $0.34 | $-0.20 | 271.7% | |
| 30 czerwca 2025 | $0.45 | $0.21 | 114.5% | |
| 31 marca 2025 | $0.10 | $-0.25 | 139.5% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $912M | $803M | $625M | $408M | $233M | $115M | $82M | $51M | $29M | $16M | |
| Cost of Revenue | $133M | $123M | $97M | $66M | $33M | $18M | $14M | $10M | $6M | $4M | |
| Gross Profit | $779M | $680M | $528M | $342M | $200M | $98M | $68M | $41M | $23M | $13M | |
| R&D Expense | $103M | $114M | $117M | $69M | $37M | $26M | $13M | $7M | $6M | $7M | |
| SG&A Expense | $625M | $530M | $452M | $321M | $203M | $128M | $90M | $54M | $32M | $23M | |
| Operating Expenses | · | · | $568M | $389M | $240M | $154M | $103M | $61M | $39M | $30M | |
| Operating Income | $51M | $36M | $-40M | $-48M | $-40M | $-56M | $-35M | $-20M | $-16M | $-17M | |
| Interest Expense | · | · | $0 | $2M | $2M | $2M | $2M | $3M | $2M | $1M | |
| Interest Income | · | · | · | · | $125.0K | $1M | $4M | $2M | $203.0K | $57.0K | |
| Other Non-op | $-3M | $-855.0K | $-195.0K | $-49.0K | $-117.0K | $145.0K | $12.0K | $-16.0K | $42.0K | $-29.0K | |
| Pretax Income | $66M | $58M | $-20M | $-44M | $-42M | $-57M | $-33M | $-22M | $-18M | $-19M | |
| Income Tax | $-80M | $5M | $1M | $613.0K | $72.0K | $115.0K | $40.0K | $0 | $0 | $0 | |
| Net Income | $145M | $54M | $-21M | $-45M | $-42M | $-57M | $-33M | $-22M | $-18M | $-19M | |
| EPS (Basic) | $4.95 | $1.80 | $-0.72 | $-1.60 | $-1.54 | $-2.19 | $-1.40 | · | · | · | |
| EPS (Diluted) | $4.89 | $1.75 | $-0.72 | $-1.60 | $-1.54 | $-2.19 | $-1.40 | · | · | · | |
| Shares (Basic) | 29,368,892 | 29,763,395 | 29,302,154 | 28,071,748 | 27,262,979 | 26,073,418 | 23,804,452 | · | · | · | |
| Shares (Diluted) | 29,757,036 | 30,543,274 | 29,302,154 | 28,071,748 | 27,262,979 | 26,073,418 | 23,804,452 | · | · | · | |
| EBITDA | $65M | $43M | $-37M | $-46M | $-39M | $-55M | $-34M | $-20M | · | · |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $105M | $150M | $186M | $442M | $214M | $191M | $23M | $97M | $9M | $7M | |
| Short-term Investments | $203M | $295M | $275M | $10M | $0 | $44M | $127M | $91M | $7M | · | |
| Receivables | $120M | $93M | $90M | $61M | $34M | $25M | $13M | $7M | $4M | · | |
| Inventory | $145M | $80M | $34M | $12M | $17M | $8M | $6M | $3M | $4M | · | |
| Prepaid Expense | $10M | $12M | $10M | $6M | $3M | $2M | $2M | $2M | $426.0K | · | |
| Current Assets | $584M | $631M | $594M | $530M | $269M | $270M | $171M | $199M | $24M | · | |
| PP&E (Net) | $98M | $72M | $40M | $17M | $8M | $5M | $3M | $802.0K | $994.0K | · | |
| PP&E (Gross) | $124M | $86M | $47M | $22M | $12M | $7M | $4M | $2M | $2M | · | |
| Accum. Depreciation | $26M | $14M | $7M | $5M | $3M | $2M | $1M | $799.0K | $810.0K | · | |
| Other Non-current Assets | $17M | $11M | $11M | $11M | $204.0K | $204.0K | $381.0K | $0 | · | · | |
| Total Assets | $907M | $808M | $677M | $565M | $295M | $281M | $181M | $200M | $25M | · | |
| Accrued Liabilities | $59M | $50M | $39M | $34M | $20M | $14M | $12M | $8M | $4M | · | |
| Short-term Debt | · | · | · | $0 | $9M | $0 | · | · | · | · | |
| Current Liabilities | $96M | $89M | $78M | $61M | $41M | $21M | $17M | $11M | $7M | · | |
| Capital Leases | $30M | $30M | $25M | $8M | $9M | $6M | $0 | · | · | · | |
| Other Non-current Liabilities | $104.0K | $148.0K | $1M | $146.0K | $134.0K | $85.0K | $40.0K | $0 | · | · | |
| Total Liabilities | $126M | $119M | $104M | $69M | $66M | $51M | $41M | $36M | $24M | · | |
| Long-term Debt | · | · | · | · | $24M | $24M | $24M | · | · | · | |
| Total Debt | · | · | · | $0 | $9M | · | · | · | · | · | |
| Common Stock | $29.0K | $30.0K | $30.0K | $29.0K | $27.0K | $27.0K | $24.0K | $23.0K | $1.0K | · | |
| Paid-in Capital | $927M | $981M | $917M | $820M | $508M | $467M | $320M | $311M | $7M | · | |
| Retained Earnings | $-146M | $-292M | $-345M | $-324M | $-279M | $-237M | $-180M | $-147M | $-125M | · | |
| AOCI | $464.0K | $536.0K | $800.0K | $-86.0K | $-55.0K | $29.0K | $102.0K | $-52.0K | $0 | · | |
| Stockholders' Equity | $781M | $690M | $573M | $496M | $229M | $230M | $140M | $164M | $1M | $-7M | |
| Liabilities + Equity | $907M | $808M | $677M | $565M | $295M | $281M | $181M | $200M | $25M | · | |
| Shares Outstanding | 28,579,015 | 29,740,176 | 29,560,464 | 29,008,368 | 27,416,106 | 27,069,276 | 24,107,350 | 23,401,675 | 1,272,360 | 1,145,238 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $14M | $7M | $3M | $2M | $1M | $840.0K | $495.0K | $393.0K | $285.0K | $103.0K | |
| Stock-based Comp | $130M | $116M | $82M | $52M | $26M | $13M | $6M | $1M | $243.0K | $248.0K | |
| Deferred Tax | $-89M | $-13.0K | $0 | $0 | · | · | · | · | · | · | |
| Other Non-cash | $-84M | $-46M | $-40M | $3M | $-5M | $-9M | $-6M | $2M | · | · | |
| Operating Cash Flow | $117M | $130M | $25M | $12M | $-20M | $-53M | $-33M | $-19M | $-16M | $-18M | |
| CapEx | $38M | $39M | $24M | $9M | $5M | $2M | $3M | $250.0K | $412.0K | $306.0K | |
| Investing Cash Flow | $21M | $-113M | $-295M | $-20M | $29M | $87M | $-44M | $-83M | $-8M | $-306.0K | |
| Net Debt Issued | · | $0 | $0 | $-24M | · | · | · | · | · | · | |
| Stock Issued | · | $0 | $0 | $244M | $0 | $125M | $0 | $182M | $0 | $0 | |
| Stock Repurchased | $175M | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $-175M | $-75M | $0 | $244M | $0 | $125M | $0 | $182M | · | · | |
| Financing Cash Flow | $-183M | $-52M | $14M | $235M | $15M | $134M | $2M | $190M | $26M | $13M | |
| Net Change in Cash | $-45M | $-35M | $-256M | $227M | $24M | $168M | $-74M | $88M | $2M | $-5M | |
| Taxes Paid | $8M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $78M | $91M | $1M | $2M | $-25M | $-56M | $-36M | $-19M | · | · | |
| Levered FCF | · | · | $1M | $772.8K | $-27M | $-58M | $-38M | $-22M | · | · |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 85.4% | 84.7% | 84.5% | 83.8% | 85.7% | 84.7% | 83.4% | 80.1% | · | · | |
| Operating Margin | 5.6% | 4.5% | -6.5% | -11.7% | -17.1% | -48.7% | -42.5% | -40.3% | · | · | |
| Net Margin | 16.0% | 6.7% | -3.4% | -11.0% | -18.0% | -49.6% | -40.5% | -43.1% | · | · | |
| Pretax Margin | 7.2% | 7.3% | -3.2% | -10.8% | -18.0% | -49.5% | -40.5% | -43.1% | · | · | |
| EBITDA Margin | 7.1% | 5.3% | -6.0% | -11.2% | -16.6% | -48.0% | -41.9% | -39.5% | · | · | |
| ROA | 17.0% | 7.2% | -3.4% | -10.4% | -14.6% | -24.7% | -17.4% | · | · | · | |
| ROE | 19.9% | 7.7% | -3.8% | -12.4% | -18.3% | -31.0% | -21.9% | · | · | · | |
| ROIC | 14.4% | 4.8% | -7.5% | -9.7% | -16.8% | -24.5% | -25.0% | · | · | · |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | 7.1 | 7.6 | 8.7 | 6.5 | 13.0 | 10.1 | · | · | · | |
| Quick Ratio | 4.5 | 6.1 | 7.0 | 8.4 | 6.0 | 12.5 | 9.6 | · | · | · | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | · | -28.4 | -18.7 | -26.6 | -16.5 | -6.2 | · | · |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.1 | 1.0 | 0.9 | 0.8 | 0.5 | 0.4 | · | · | · | |
| Inventory Turnover | 1.2 | 2.2 | 4.2 | 4.5 | 2.6 | 2.5 | 3.2 | · | · | · | |
| Receivables Turnover | 8.6 | 8.8 | 8.3 | 8.5 | 7.9 | 6.0 | 8.3 | · | · | · |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $27.33 | $23.19 | $19.37 | $17.10 | $8.35 | $8.49 | $5.80 | · | · | · | |
| Revenue / Share | $30.65 | $26.28 | $21.32 | $14.53 | $8.56 | · | · | · | · | · | |
| Cash Flow / Share | $3.93 | $4.26 | $0.84 | $0.41 | $-0.74 | · | · | · | · | · | |
| Cash / Share | $3.67 | $5.05 | $6.28 | $15.22 | $7.82 | $7.04 | $0.95 | · | · | · | |
| EPS (TTM) | $4.89 | $1.75 | $-0.72 | $-1.60 | $-1.54 | $-2.19 | $-1.40 | · | · | · |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.6% | 28.5% | 53.2% | 74.8% | 102.3% | · | · | · | · | · | |
| Revenue CAGR 3Y | 30.8% | 50.9% | 75.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 51.2% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 179.4% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 171.8% | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $912M | $803M | $625M | $408M | $233M | $115M | $82M | $51M | · | · | |
| Net Income TTM | $145M | $54M | $-21M | $-45M | $-42M | $-57M | $-33M | $-22M | · | · | |
| Market Cap | $2.64B | $5.51B | $6.01B | $7.31B | $6.31B | $5.09B | $1.79B | · | · | · | |
| Enterprise Value | · | · | · | $6.86B | $6.10B | · | · | · | · | · | |
| P/E | 18.9 | 105.9 | -282.5 | -157.4 | -149.4 | -85.9 | -53.0 | · | · | · | |
| P/S | 2.9 | 6.9 | 9.6 | 17.9 | 27.0 | 44.1 | 21.8 | · | · | · | |
| P/B | 3.4 | 8.0 | 10.5 | 14.7 | 27.5 | 22.2 | 12.8 | · | · | · | |
| P / Tangible Book | 3.4 | 8.0 | 10.5 | 14.7 | 27.5 | 22.2 | · | · | · | · | |
| P / Cash Flow | 22.5 | 42.3 | 243.9 | 631.6 | -313.5 | -96.0 | -54.5 | · | · | · | |
| P / FCF | 33.6 | 60.5 | 5872.5 | 2954.6 | -254.5 | -91.7 | -50.3 | · | · | · | |
| EV / EBITDA | · | · | · | -149.9 | -158.0 | · | · | · | · | · | |
| EV / FCF | · | · | · | 2772.0 | -246.2 | · | · | · | · | · | |
| EV / Revenue | · | · | · | 16.8 | 26.1 | · | · | · | · | · | |
| Earnings Yield | 5.3% | 0.94% | -0.35% | -0.64% | -0.67% | -1.2% | -1.9% | · | · | · |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $201M | $205M | $269M | $225M | $217M | $201M | $240M | $203M | $196M | $164M | $193M | $153M | $151M | $128M | $138M | $109M | |
| Cost of Revenue | $29M | $28M | $36M | $32M | $35M | $31M | $36M | $32M | $30M | $25M | $28M | $24M | $24M | $20M | $22M | $20M | |
| Gross Profit | $171M | $177M | $233M | $193M | $182M | $171M | $204M | $171M | $166M | $139M | $164M | $129M | $127M | $108M | $116M | $89M | |
| R&D Expense | $25M | $26M | $25M | $24M | $26M | $28M | $30M | $26M | $29M | $29M | $31M | $29M | $31M | $26M | $21M | $21M | |
| SG&A Expense | $147M | $152M | $162M | $159M | $160M | $144M | $142M | $130M | $132M | $126M | $124M | $113M | $113M | $102M | $95M | $86M | |
| Operating Expenses | · | · | · | · | · | · | · | $156M | $161M | $154M | · | $142M | $143M | $128M | · | $107M | |
| Operating Income | $-514.0K | $-1M | $46M | $10M | $-3M | $-1M | $32M | $14M | $5M | $-15M | $9M | $-13M | $-17M | $-19M | $-335.0K | $-17M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $656.0K | |
| Other Non-op | $-110.0K | $-226.0K | $330.0K | $-66.0K | $-3M | $578.0K | $-778.0K | $118.0K | $-135.0K | $-60.0K | $73.0K | $-224.0K | $-61.0K | $17.0K | $241.0K | $-101.0K | |
| Pretax Income | $3M | $2M | $50M | $14M | $-2M | $4M | $37M | $20M | $11M | $-9M | $15M | $-8M | $-12M | $-15M | $3M | $-17M | |
| Income Tax | $3M | $14M | $-86M | $4M | $1M | $1M | $1M | $2M | $1M | $650.0K | $477.0K | $340.0K | $214.0K | $216.0K | $125.0K | $246.0K | |
| Net Income | $314.0K | $-11M | $136M | $10M | $-4M | $3M | $35M | $18M | $10M | $-10M | $15M | $-9M | $-12M | $-15M | $3M | $-17M | |
| EPS (Basic) | $0.01 | $-0.39 | $4.63 | $0.34 | $-0.12 | $0.10 | $1.19 | $0.62 | $0.33 | $-0.34 | $0.51 | $-0.29 | $-0.41 | $-0.53 | $0.14 | $-0.60 | |
| EPS (Diluted) | $0.01 | $-0.39 | $4.57 | $0.34 | $-0.12 | $0.10 | $1.17 | $0.60 | $0.32 | $-0.34 | $0.51 | $-0.29 | $-0.41 | $-0.53 | $0.14 | $-0.60 | |
| Shares (Basic) | 28,835,058 | 28,700,525 | · | 29,332,376 | 29,506,807 | 29,702,358 | · | 29,879,621 | 29,728,849 | 29,615,166 | · | 29,365,968 | 29,229,922 | 29,089,950 | · | 28,226,345 | |
| Shares (Diluted) | 28,940,846 | 28,700,525 | · | 29,600,223 | 29,506,807 | 30,311,476 | · | 30,633,789 | 30,408,439 | 29,615,166 | · | 29,365,968 | 29,229,922 | 29,089,950 | · | 28,226,345 | |
| EBITDA | $-514.0K | $4M | · | $10M | $-3M | $2M | · | $14M | $5M | $-14M | · | $-13M | $-17M | $-19M | · | $-17M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $128M | $99M | $105M | $113M | $107M | $54M | $150M | $148M | $188M | $175M | · | $330M | $467M | $442M | · | $418M | |
| Short-term Investments | $193M | $185M | $203M | $210M | $194M | $315M | $295M | $263M | $252M | $266M | · | $134M | $0 | $10M | · | $10M | |
| Receivables | $103M | $105M | $120M | $108M | $138M | $93M | $93M | $90M | $80M | $72M | · | $71M | $64M | $60M | · | $48M | |
| Inventory | $170M | $166M | $145M | $142M | $122M | $100M | $80M | $67M | $59M | $49M | · | $26M | $21M | $16M | · | $15M | |
| Prepaid Expense | $14M | $12M | $10M | $14M | $13M | $10M | $12M | $14M | $29M | $10M | · | $8M | $9M | $6M | · | $4M | |
| Current Assets | $609M | $567M | $584M | $586M | $573M | $572M | $631M | $583M | $607M | $572M | · | $570M | $560M | $534M | · | $496M | |
| PP&E (Net) | $104M | $101M | $98M | $92M | $85M | $77M | $72M | $67M | $62M | $52M | · | $32M | $25M | $21M | · | $14M | |
| PP&E (Gross) | · | · | $124M | $115M | $105M | $94M | $86M | $79M | $71M | $60M | · | $39M | $31M | $26M | · | $18M | |
| Accum. Depreciation | · | · | $26M | $24M | $20M | $17M | $14M | $11M | $9M | $8M | · | $7M | $6M | $6M | · | $4M | |
| Other Non-current Assets | $18M | $17M | $17M | $17M | $9M | $12M | $11M | $11M | $11M | $11M | · | $12M | $12M | $11M | · | $11M | |
| Total Assets | $926M | $911M | $907M | $808M | $802M | $731M | $808M | $796M | $728M | $686M | · | $639M | $618M | $572M | · | $528M | |
| Accrued Liabilities | $44M | $48M | $59M | $52M | $40M | $34M | $50M | $39M | $32M | $28M | · | $30M | $27M | $23M | · | $29M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Current Liabilities | $71M | $89M | $96M | $111M | $93M | $63M | $89M | $74M | $66M | $72M | · | $70M | $67M | $60M | · | $49M | |
| Capital Leases | $29M | $30M | $30M | $30M | $31M | $31M | $30M | $25M | $25M | $24M | · | $25M | $22M | $7M | · | $8M | |
| Other Non-current Liabilities | $136.0K | $66.0K | $104.0K | $111.0K | $111.0K | $108.0K | $148.0K | $150.0K | $149.0K | $146.0K | · | $146.0K | $146.0K | $146.0K | · | $146.0K | |
| Total Liabilities | $100M | $119M | $126M | $141M | $124M | $95M | $119M | $100M | $90M | $97M | · | $95M | $89M | $67M | · | $57M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Common Stock | $29.0K | $29.0K | $29.0K | $29.0K | $29.0K | $29.0K | $30.0K | $30.0K | $30.0K | $30.0K | · | $29.0K | $29.0K | $29.0K | · | $29.0K | |
| Paid-in Capital | $984M | $950M | $927M | $948M | $970M | $924M | $981M | $1.02B | $984M | $944M | · | $904M | $881M | $844M | · | $798M | |
| Retained Earnings | $-157M | $-158M | $-146M | $-283M | $-293M | $-289M | $-292M | $-327M | $-346M | $-355M | · | $-360M | $-352M | $-340M | · | $-327M | |
| AOCI | $-645.0K | $-352.0K | $464.0K | $639.0K | $396.0K | $227.0K | $536.0K | $2M | $-115.0K | $124.0K | · | $44.0K | $103.0K | $32.0K | · | $-363.0K | |
| Stockholders' Equity | $826M | $792M | $781M | $666M | $678M | $636M | $690M | $697M | $638M | $589M | $573M | $544M | $529M | $505M | $496M | $470M | |
| Liabilities + Equity | $926M | $911M | $907M | $808M | $802M | $731M | $808M | $796M | $728M | $686M | · | $639M | $618M | $572M | · | $528M | |
| Shares Outstanding | 28,907,221 | 28,802,039 | 28,579,015 | 29,053,367 | 29,569,477 | 29,467,300 | 29,740,176 | 29,963,260 | 29,805,301 | 29,676,095 | 29,560,464 | 29,403,189 | 29,326,179 | 29,163,001 | 29,008,368 | 28,820,680 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $5M | $4M | $4M | $3M | $3M | $2M | $2M | $1M | $839.0K | $817.0K | $777.0K | $659.0K | $593.0K | $569.0K | $513.0K | |
| Stock-based Comp | $31M | $31M | $28M | $30M | $42M | $31M | $29M | $28M | $32M | $26M | $23M | $20M | $22M | $18M | $15M | $15M | |
| Deferred Tax | $10M | $1M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-13M | · | · | · | $-44M | · | · | · | $-8M | · | · | · | $-5M | · | · | |
| Operating Cash Flow | $23M | $13M | $52M | $69M | $3M | $-7M | $69M | $52M | $-78.0K | $9M | $17M | $4M | $5M | $-1M | $19M | $11M | |
| CapEx | $9M | $10M | $11M | $10M | $9M | $8M | $7M | $8M | $12M | $12M | $8M | $7M | $5M | $4M | $3M | $4M | |
| Investing Cash Flow | $4M | $-11M | $-12M | $-12M | $47M | $-2M | $4M | $-103M | $6M | $-20M | $-152M | $-144M | $5M | $-4M | $-3M | $-4M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Stock Repurchased | $0 | $0 | $50M | $50M | $0 | $75M | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $-75M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $2M | $-7M | $-48M | $-51M | $4M | $-88M | $-70M | $10M | $7M | $768.0K | $-10M | $4M | $15M | $6M | $7M | $224M | |
| Net Change in Cash | $29M | $-6M | $-8M | $6M | $53M | $-96M | $3M | $-41M | $13M | $-10M | $-144M | $-137M | $25M | $540.0K | $24M | $231M | |
| Free Cash Flow | · | $3M | · | · | · | $-15M | · | · | · | $-3M | · | · | · | $-5M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | $-5M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 85.5% | 86.5% | · | 85.9% | 84.0% | 84.8% | · | 84.1% | 84.8% | 84.9% | · | 84.1% | 84.0% | 84.5% | · | 81.9% | |
| Operating Margin | -0.26% | -0.55% | · | 4.3% | -1.5% | -0.74% | · | 7.0% | 2.6% | -9.3% | · | -8.8% | -11.0% | -15.2% | · | -15.8% | |
| Net Margin | 0.16% | -5.5% | · | 4.4% | -1.7% | 1.5% | · | 9.1% | 5.0% | -6.1% | · | -5.6% | -7.9% | -12.1% | · | -15.4% | |
| Pretax Margin | 1.6% | 1.2% | · | 6.0% | -1.1% | 2.1% | · | 10.0% | 5.5% | -5.7% | · | -5.3% | -7.8% | -11.9% | · | -15.2% | |
| EBITDA Margin | -0.26% | 1.9% | · | 4.3% | -1.5% | 0.77% | · | 7.0% | 2.6% | -8.8% | · | -8.8% | -11.0% | -14.8% | · | -15.8% | |
| ROA | 0.04% | -1.4% | · | 1.2% | -0.47% | 0.42% | · | 2.6% | 1.5% | -1.6% | · | -1.5% | -2.6% | -3.6% | · | -4.2% | |
| ROE | 0.04% | -1.6% | · | 1.5% | -0.55% | 0.49% | · | 3.0% | 1.7% | -1.8% | · | -1.7% | -3.2% | -4.2% | · | -4.9% | |
| ROIC | -0.01% | 0.66% | · | 1.1% | -0.75% | -0.17% | · | 1.9% | 0.72% | -2.8% | · | -2.6% | -3.2% | -3.9% | · | -3.7% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.6 | 6.3 | · | 5.3 | 6.1 | 9.0 | · | 7.8 | 9.2 | 7.9 | · | 8.1 | 8.4 | 8.9 | · | 10.1 | |
| Quick Ratio | 6.0 | 4.3 | · | 3.9 | 4.7 | 7.3 | · | 6.7 | 7.9 | 7.1 | · | 7.7 | 8.0 | 8.5 | · | 9.7 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -26.2 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 0.2 | 0.2 | · | 0.3 | 0.4 | 0.4 | · | 0.7 | 0.7 | 0.8 | · | 1.2 | 1.1 | 1.1 | · | 1.3 | |
| Receivables Turnover | 1.7 | 2.1 | · | 2.3 | 2.0 | 2.4 | · | 2.5 | 2.7 | 2.5 | · | 2.6 | 2.9 | 2.7 | · | 2.9 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $28.56 | $27.51 | · | $22.94 | $22.92 | $21.57 | · | $23.25 | $21.41 | $19.85 | · | $18.51 | $18.05 | $17.30 | · | $16.31 | |
| Revenue / Share | $6.93 | $7.13 | · | $7.58 | $7.36 | $6.64 | · | $6.63 | $6.44 | $5.54 | · | $5.22 | $5.17 | $4.40 | · | $3.87 | |
| Cash Flow / Share | · | $0.45 | · | · | · | $-0.22 | · | · | · | $0.30 | · | · | · | $-0.05 | · | · | |
| Cash / Share | $4.42 | $3.43 | · | $3.88 | $3.62 | $1.83 | · | $4.92 | $6.31 | $5.91 | · | $11.22 | $15.93 | $15.16 | · | $14.50 | |
| EPS (TTM) | $4.53 | $4.40 | · | $1.49 | $1.75 | $2.19 | · | $1.09 | $0.20 | $-0.53 | · | $-1.09 | $-1.40 | $-1.52 | · | $-1.82 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $899M | $915M | · | $883M | $861M | $840M | · | $756M | $706M | $661M | · | $570M | $526M | $466M | · | $348M | |
| Net Income TTM | $135M | $131M | · | $45M | $53M | $67M | · | $33M | $6M | $-16M | · | $-33M | $-41M | $-44M | · | $-50M | |
| Market Cap | $1.29B | $1.49B | · | $2.16B | $3.84B | $4.69B | · | $6.32B | $3.99B | $6.37B | · | $5.83B | $9.52B | $6.83B | · | $5.11B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $4.68B | |
| P/E | 9.8 | 11.7 | · | 49.8 | 74.2 | 72.7 | · | 193.6 | 669.1 | -405.3 | · | -182.1 | -231.9 | -154.0 | · | -97.5 | |
| P/S | 1.4 | 1.6 | · | 2.4 | 4.5 | 5.6 | · | 8.4 | 5.7 | 9.6 | · | 10.2 | 18.1 | 14.6 | · | 14.7 | |
| P/B | 1.6 | 1.9 | · | 3.2 | 5.7 | 7.4 | · | 9.1 | 6.3 | 10.8 | · | 10.7 | 18.0 | 13.5 | · | 10.9 | |
| P / Tangible Book | 1.6 | 1.9 | · | 3.2 | 5.7 | 7.4 | · | 9.1 | 6.3 | 10.8 | · | 10.7 | 18.0 | 13.5 | · | 10.9 | |
| P / Cash Flow | · | 115.6 | · | · | · | -700.2 | · | · | · | 719.4 | · | · | · | -5079.0 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 13.4 | |
| Earnings Yield | 10.2% | 8.5% | · | 2.0% | 1.4% | 1.4% | · | 0.52% | 0.15% | -0.25% | · | -0.55% | -0.43% | -0.65% | · | -1.0% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $912M | $803M | $625M | $408M | $233M |
| Marża Brutto % | 85.4% | 84.7% | 84.5% | 83.8% | 85.7% |
| Marża Operacyjna % | 5.6% | 4.5% | -6.5% | -11.7% | -17.1% |
| Zysk netto | $145M | $54M | $-21M | $-45M | $-42M |
| Rozwodniony EPS | $4.89 | $1.75 | $-0.72 | $-1.60 | $-1.54 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | · | · | · | 0.0 | 0.0 |
| Wskaźnik bieżący | 6.1 | 7.1 | 7.6 | 8.7 | 6.5 |
| Wskaźnik Szybkości | 4.5 | 6.1 | 7.0 | 8.4 | 6.0 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $78M | $91M | $1M | $2M | $-25M |
Właściciele instytucjonalni (13F) 305 emitentów · $1.9B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
305
Wartość posiadanych akcji
$1.9B
Nowe pozycje
63
Zamknięte pozycje
88
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 63 (-2 vs poprzedni kw.) | 88 (-1 vs poprzedni kw.) | 98 (-20 vs poprzedni kw.) | 81 (-21 vs poprzedni kw.) | +1.7M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $272 370 870 | 2 953 170 | 14,23% | Akcje |
| BlackRock, Inc. | $211 340 721 | 4 737 519 | 11,04% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $106 290 462 | 2 382 660 | 5,55% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $93 188 550 | 2 088 961 | 4,87% | Akcje |
| Soleus Capital Management, L.P. | $86 161 360 | 1 931 436 | 4,50% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $80 937 912 | 1 856 800 | 4,23% | Akcje |
| UBS Group AG | $73 406 245 | 1 645 511 | 3,84% | Akcje |
| D. E. Shaw & Co., Inc. | $65 597 310 | 1 470 462 | 3,43% | Akcje |
| NOMURA HOLDINGS INC | $61 089 380 | 1 369 410 | 3,19% | Akcje |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $57 853 014 | 1 296 862 | 3,02% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $56 696 098 | 1 270 928 | 2,96% | Akcje |
| STATE STREET CORP | $53 821 697 | 1 206 494 | 2,81% | Akcje |
| Assenagon Asset Management S.A. | $38 560 661 | 864 395 | 2,01% | Akcje |
| MORGAN STANLEY | $35 296 449 | 791 222 | 1,84% | Akcje |
| Artisan Partners Limited Partnership | $32 668 929 | 732 323 | 1,71% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $31 270 244 | 700 836 | 1,63% | Akcje |
| BRAIDWELL LP | $30 226 398 | 677 570 | 1,58% | Akcje |
| GOLDMAN SACHS GROUP INC | $28 811 726 | 645 858 | 1,51% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $23 148 434 | 448 787 | 1,21% | Akcje |
| CITADEL ADVISORS LLC | $22 587 560 | 506 334 | 1,18% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $19 096 158 | 428 069 | 1,00% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $19 003 860 | 426 000 | 0,99% | Akcje |
| ADAR1 Capital Management, LLC | $16 711 664 | 374 617 | 0,87% | Akcje |
| Aberdeen Group plc | $16 013 562 | 358 968 | 0,84% | Akcje |
| NORTHERN TRUST CORP | $14 901 479 | 334 039 | 0,78% | Akcje |
| BARCLAYS PLC | $13 707 315 | 307 270 | 0,72% | Akcje |
| FEDERATED HERMES, INC. | $12 139 719 | 272 130 | 0,63% | Akcje |
| Nantahala Capital Management, LLC | $12 021 235 | 269 474 | 0,63% | Akcje |
| FMR LLC | $11 949 708 | 267 871 | 0,62% | Akcje |
| BANK OF AMERICA CORP /DE/ | $11 099 059 | 248 802 | 0,58% | Akcje |
| Walleye Capital LLC | $10 963 487 | 245 763 | 0,57% | Akcje |
| Rock Springs Capital Management LP | $10 884 840 | 244 000 | 0,57% | Akcje |
| CAPITAL FUND MANAGEMENT S.A. | $9 808 534 | 219 873 | 0,51% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9 372 160 | 210 091 | 0,49% | Akcje |
| NORGES BANK | $8 844 914 | 198 272 | 0,46% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $8 501 015 | 190 563 | 0,44% | Akcje |
| DEUTSCHE BANK AG\ | $7 860 282 | 176 200 | 0,41% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $7 543 328 | 169 095 | 0,39% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $7 365 111 | 165 100 | 0,38% | Akcje |
| Cubist Systematic Strategies, LLC | $7 226 073 | 97 387 | 0,38% | Akcje |
| WASATCH ADVISORS LP | $7 149 143 | 138 603 | 0,37% | Akcje |
| Bank of New York Mellon Corp | $6 630 271 | 148 627 | 0,35% | Akcje |
| Congress Wealth Management LLC / DE / | $6 483 508 | 49 960 | 0,34% | Akcje |
| BANK OF NOVA SCOTIA | $6 466 844 | 144 964 | 0,34% | Akcje |
| Quantinno Capital Management LP | $6 139 005 | 137 615 | 0,32% | Akcje |
| Edgestream Partners, L.P. | $5 967 301 | 133 766 | 0,31% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $5 717 886 | 128 175 | 0,30% | Akcje |
| Alberta Investment Management Corp | $5 482 569 | 122 900 | 0,29% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $5 171 164 | 115 907 | 0,27% | Akcje |
| Invesco Ltd. | $4 919 814 | 110 285 | 0,26% | Akcje |
Insiderzy spółki 25 insiderów · 11 dyrektorzy generalni · 15 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Timothy P. Herbert | CEO and President | 20 lutego 2026 A | 99 834 | 0 | 0 | $0 |
| Richard Buchholz | Interim CFO | 13 lutego 2026 F | 43 988 | 0 | 0 | $0 |
| Philip Ebeling | Chief Operating Officer | 9 lutego 2024 A | 3 027 | 0 | 0 | $0 |
| Jason P Kelly | Title - Chief Operations and Innovation Officer | 31 sierpnia 2026 A | 25 335 | 0 | 1 | $-57 347 |
| Melissa Mann | Chief People Officer | 31 lipca 2026 F | 22 957 | 0 | 0 | $0 |
| John Rondoni | Title: Chief Product and Innovation Officer. | 15 maja 2026 S | 27 165 | 0 | 3 | $-155 309 |
| Carlton Weatherby | Chief Strategy and Growth Officer. | 20 lutego 2026 A | 41 679 | 0 | 0 | $0 |
| Bryan K Phillips | Senior Vice President, General Counsel, Secretary and Chief Compliance Officer. | 20 lutego 2026 A | 38 513 | 0 | 0 | $0 |
| Randy Ban | Executive Vice President, Patient Access and Therapy Development. All transactions reported herein were made pursuant to a Rule | 3 marca 2025 S | 7 259 | 0 | 0 | $0 |
| Charisse Y Sparks | Chief Medical Officer | 29 maja 2024 G | 3 628 | 0 | 0 | $0 |
| Steven Jandrich | VP, Human Resources | 30 stycznia 2024 M | 23 096 | 0 | 0 | $0 |
| Michael H Carrel | Dyrektor | 20 lipca 2026 A | 5 631 | 0 | 0 | $0 |
| Georgia Melenikiotou | Dyrektor | 15 lipca 2026 A | 8 329 | 0 | 0 | $0 |
| Casey M Tansey | Dyrektor | 15 lipca 2026 A | 26 632 | 0 | 0 | $0 |
| Shelley G. Broader | Dyrektor | 15 lipca 2026 A | 8 854 | 0 | 0 | $0 |
| Gary Lee Ellis | Dyrektor | 15 lipca 2026 A | 11 419 | 0 | 0 | $0 |
| Shawn Mccormick | Dyrektor | 8 maja 2026 S | 27 712 | 0 | 3 | $-453 296 |
| Cynthia Burks | Dyrektor | 30 kwietnia 2026 A | 6 213 | 0 | 0 | $0 |
| Myriam Curet | Dyrektor | 30 kwietnia 2026 A | 6 927 | 2 | 2 | $188 |
| Dana G Mead Jr. | Dyrektor | 30 kwietnia 2026 A | 26 213 | 0 | 0 | $0 |
| Marilyn C Nelson | Dyrektor | 29 kwietnia 2024 M | 35 620 | 0 | 0 | $0 |
| Jerry C Griffin | Dyrektor | 1 kwietnia 2024 M | 10 900 | 0 | 0 | $0 |
| Chau Quang Khuong | Dyrektor | 9 października 2020 A | 1 875 | 0 | 0 | $0 |
| Mudit K. Jain | Dyrektor | 10 lipca 2020 A | 1 303 | 0 | 0 | $0 |
| Joyce Erony | Dyrektor | 18 lipca 2019 S | 103 939 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 43 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| RNIN · EA Series Trust | 1,30% | 47 139 NS | 31 lipca 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,08% | 27 786 SH | 1 października 2026 | Dziennie |
| IHI · iShares Trust | 0,27% | 125 184 SH | 11 września 2026 | Dziennie |
| RZG · Invesco Exchange-Traded Fund Trust | 0,18% | 3 154 SH | 1 października 2026 | Dziennie |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,13% | 31 208 SH | 19 sierpnia 2026 | Dziennie |
| IWO · iShares Trust | 0,11% | 236 867 SH | 11 września 2026 | Dziennie |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,11% | 3 752 SH | 1 października 2026 | Dziennie |
| CALF · Pacer Funds Trust | 0,11% | 79 486 NS | 31 lipca 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,10% | 38 472 SH | 1 października 2026 | Dziennie |
| VFVA · VANGUARD WELLINGTON FUND | 0,07% | 12 690 SH | 19 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,07% | 26 969 SH | 19 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,06% | 741 263 SH | 11 września 2026 | Dziennie |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,06% | 2 347 SH | 1 października 2026 | Dziennie |
| ISCG · iShares Trust | 0,06% | 8 720 SH | 11 września 2026 | Dziennie |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,06% | 17 026 SH | 1 października 2026 | Dziennie |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,06% | 91 482 SH | 19 sierpnia 2026 | Dziennie |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 7 453 NS | 31 lipca 2026 | N-PORT |
| RSSL · Global X Funds | 0,05% | 13 898 NS | 31 lipca 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,04% | 384 192 SH | 19 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 166 988 SH | 19 sierpnia 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,02% | 662 414 SH | 19 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,02% | 77 993 SH | 19 sierpnia 2026 | Dziennie |
| RILA · Spinnaker ETF Series | 0,02% | 144 NS | 31 lipca 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 12 317 NS | 31 lipca 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,02% | 1 706 NS | 31 lipca 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 1 483 SH | 11 września 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 302 193 SH | 19 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 3 380 SH | 19 sierpnia 2026 | Dziennie |
| TILT · FlexShares Trust | 0,01% | 2 844 NS | 31 lipca 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,01% | 157 NS | 31 lipca 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 7 913 SH | 11 września 2026 | Dziennie |
| ITOT · iShares Trust | 0,00% | 35 282 SH | 11 września 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 914 149 SH | 19 sierpnia 2026 | Dziennie |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 23 081 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2 373 SH | 19 sierpnia 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,00% | 6 436 SH | 19 sierpnia 2026 | Dziennie |
| LSEQ · Harbor ETF Trust | -1,78% | -5 429 NS | 31 lipca 2026 | N-PORT |
| IJR · iShares Trust | · | 1 599 632 SH | 10 września 2026 | Dziennie |
| IJT · iShares Trust | · | 248 006 SH | 9 września 2026 | Dziennie |
| IWN · iShares Trust | · | 35 354 SH | 11 września 2026 | Dziennie |
| XJR · iShares Trust | · | 3 607 SH | 31 sierpnia 2026 | Dziennie |
| ISCB · iShares Trust | · | 1 214 SH | 11 września 2026 | Dziennie |
| SMLF · iShares Trust | · | 15 841 SH | 11 września 2026 | Dziennie |
INSP Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 24 analityków
TRZYMAJ
Średni cel
$60.00
-14,2%
4 16,7%
Mocne kupno
5 20,8%
Kup
13 54,2%
Trzymaj
2 8,3%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
15 analityków · 2026-09-27Średnia cel $62.80 -10,2%
Teraz
Aktualna cena $69.97
Niski$40.00
Średnia$62.80
Wysoki$97.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| INSP | $2.64B | 18.9 | 13.6% | 16.0% | 19.9% | 85.4% |
| ASST | · | -0.1 | 1217.5% | · | · | · |
| ATRC | $1.97B | -164.8 | 14.9% | -2.1% | -2.4% | 75.0% |
| TMDX | $4.17B | 25.0 | 37.1% | 31.4% | 48.1% | 59.9% |
| BFLY | · | -12.3 | 19.0% | -79.0% | -35.9% | 46.9% |
| AXGN | $1.54B | -96.3 | 20.2% | -7.0% | -13.0% | 74.3% |
| LMAT | $1.85B | 32.2 | 13.5% | 23.1% | 15.3% | 71.5% |
| KMTS | $1.21B | -8.5 | 59.0% | -138.4% | -62.1% | 51.4% |
| ATEC | $3.16B | -21.9 | 24.9% | -18.8% | -792.1% | 69.6% |
| OMCL | $2.04B | 1132.5 | 6.5% | 0.17% | 0.16% | 42.5% |
| CNMD | $1.27B | 26.9 | 5.2% | 3.4% | 4.6% | 54.6% |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 3, 2026